Read more about our CLIA (Clinical Laboratory Improvement Amendments) licenses and CAP (College of American Pathologists) accreditation. Search job openings at the Quest GIC in India.More about our business in Mexico (in English)īased out of Hyderabad, India, the Quest Global Information Center of Excellence (GIC) is the technology and engineering center of excellence dedicated to leading transformation and innovation efforts by utilizing modern platforms in social, mobile, analytics, and cloud domains to aid the company promise of Action from Insight.More about our business in Mexico (in Spanish).We offer domestic and international testing services, including clinical trials, drug screening, life insurance assessments and specialized, complex testing. With two central labs accredited by the College of American Pathologists (CAP) and approximately 35 patient locations, Quest Diagnostics Mexico is one of the preeminent private clinical laboratories in Mexico City and Ciudad Juarez. Since then, Quest Diagnostics has helped to improve the delivery of timely results for patients and expanded its service offering in Ireland. In 2006, the Ireland national health administration engaged with us to help reduce a critical backlog of Pap-based cervical cancer screening tests. To serve the Brazilian market, we provide information technology and logistics solutions that enable seamless support to healthcare providers and patients. Read more about our products and services.Make an appointment at a patient testing location.We offer broad access to clinical testing services through our national network of laboratories in most major metropolitan areas as well as approximately 2,000 patient locations. We also collaborate with many international diagnostic laboratories, hospitals and clinics to help improve human health around the world. Our products and services are used by customers in over 130 countries. and operations in India, Ireland, and Mexico. To learn more about the Biopsies Save Lives program, visit Diagnostics has headquarters in the U.S.
Rare Disease Day is an observance held on the last day of February to raise awareness of rare diseases and improve access to treatment and medical representation for individuals with rare diseases and their families. “This is a great, real-world example of how we are working together to create a healthier world, one life at a time, and highlights the positive impact our work has on patients,” said Cynita Smith-Watson, Senior Manager, Regional Contracting for Q4HE. Through Biopsies Save Lives, patients better understand their blistering diseases, how to ask their providers questions, and are connected to expert dermatologists. The no-cost laboratory testing that Quest is providing has been critical for our patients, and the support has been a blessing for underserved communities with erosive and blistering diseases in Los Angeles County.” “Biopsies Save Lives breaks down financial barriers to laboratory testing and turns the scariest part of healthcare-waiting for results from a potentially life-changing test-into one that is most welcoming, supportive, and educational. “We are very thankful to Quest Diagnostics and their Quest for Health Equity initiative for supporting the Biopsies Save Lives program,” said WesternU Health Oral Pathology Laboratory Director Mark Mintline, DDS. Since the collaboration between Q4HE and WesternU started, the Biopsies Save Lives program has helped lead to the potentially life-saving diagnosis of 3 patients affected by these rare diseases. The program offers no-cost testing to patients who are low-income, uninsured, and/or underinsured and who also have rare erosive and blistering diseases, and enables faster diagnosis and treatment of these conditions. Last year, we announced that Quest Diagnostics teamed up with Western University of Health Sciences (WesternU) to offer no-cost diagnostic testing services to support Biopsies Save Lives as part of the Quest for Health Equity (Q4HE) initiative.
In honor of Rare Disease Day on February 29, we’re highlighting a program dedicated to diagnosing and treating patients in underserved communities in Southern California affected by the rare autoimmune diseases pemphigus and pemphigoid, which can be life-threatening if left untreated.